SGIOF
Price:
$14.17
Market Cap:
$1.86T
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-117957 for Insomnia; sivopixant for Neuropathic pain, Sleep Apnea Syndrome, and Refractory/unexplainedchronic cough; S-637880 for Neuropathic Low Back Pain; Zuranolone for Depression; SDT-001 for attention-deficit/hyperactivity disorder patients; BPN1...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-02-28
Stock Exchange
PNK
Ticker
SGIOF
According to Shionogi & Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 12.11. This represents a change of -6.26% compared to the average of 12.92 of the last 4 quarters.
The mean historical PE Ratio of Shionogi & Co., Ltd. over the last ten years is 18.32. The current 12.11 PE Ratio has changed 6.51% with respect to the historical average. Over the past ten years (40 quarters), SGIOF's PE Ratio was at its highest in in the June 2015 quarter at 39.99. The PE Ratio was at its lowest in in the December 2022 quarter at 4.84.
Average
18.32
Median
16.23
Minimum
9.62
Maximum
30.19
Discovering the peaks and valleys of Shionogi & Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 97.11%
Maximum Annual PE Ratio = 30.19
Minimum Annual Increase = -51.61%
Minimum Annual PE Ratio = 9.62
Year | PE Ratio | Change |
---|---|---|
2024 | 13.60 | 41.41% |
2023 | 9.62 | -51.61% |
2022 | 19.88 | 21.93% |
2021 | 16.31 | 21.35% |
2020 | 13.44 | -16.79% |
2019 | 16.15 | 0.79% |
2018 | 16.02 | -27.56% |
2017 | 22.12 | -14.47% |
2016 | 25.86 | -14.33% |
2015 | 30.19 | 97.11% |
The current PE Ratio of Shionogi & Co., Ltd. (SGIOF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
14.37
5-year avg
14.57
10-year avg
18.32
Shionogi & Co., Ltd.’s PE Ratio is less than Taisho Pharmaceutical Holdings Co., Ltd. (68.13), greater than Vivesto AB (-0.37), greater than Acorda Therapeutics, Inc. (-0.00), greater than Pacira BioSciences, Inc. (-9.90), greater than Shionogi & Co., Ltd. (12.06), greater than Sunshine Biopharma, Inc. (-0.97), greater than Alimera Sciences, Inc. (-20.50), greater than China SXT Pharmaceuticals, Inc. (-0.06), greater than Guardion Health Sciences, Inc. (0.65), greater than Cresco Labs Inc. (-4.38), greater than Curaleaf Holdings, Inc. (-5.67), greater than Trulieve Cannabis Corp. (-7.09), greater than Journey Medical Corporation (-5.03), greater than Aurora Cannabis Inc. (-0.44), less than Ironwood Pharmaceuticals, Inc. (29.47), greater than Assertio Holdings, Inc. (-1.22), less than Neurocrine Biosciences, Inc. (35.77), greater than Deciphera Pharmaceuticals, Inc. (-11.74), greater than Esperion Therapeutics, Inc. (-5.17),
Company | PE Ratio | Market cap |
---|---|---|
68.13 | $4.42B | |
-0.37 | $13.26M | |
-0.00 | $821.03K | |
-9.90 | $898.99M | |
12.06 | $11.91B | |
-0.97 | $6.48M | |
-20.50 | $301.29M | |
-0.06 | $1.36M | |
0.65 | $4.35M | |
-4.38 | $374.59M | |
-5.67 | $1.15B | |
-7.09 | $912.47M | |
-5.03 | $93.80M | |
-0.44 | $234.33M | |
29.47 | $737.73M | |
-1.22 | $83.65M | |
35.77 | $13.82B | |
-11.74 | $2.21B | |
-5.17 | $453.18M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shionogi & Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Shionogi & Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Shionogi & Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Shionogi & Co., Ltd. (SGIOF)?
What is the highest PE Ratio for Shionogi & Co., Ltd. (SGIOF)?
What is the 3-year average PE Ratio for Shionogi & Co., Ltd. (SGIOF)?
What is the 5-year average PE Ratio for Shionogi & Co., Ltd. (SGIOF)?
How does the current PE Ratio for Shionogi & Co., Ltd. (SGIOF) compare to its historical average?